TGF‐β1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors

Fibroblasts have a major role in the synthesis and reorganization of extracellular matrix that occur during wound repair. An impaired biosynthetic or functional response of these cells to stimulation by growth factors might contribute to the delayed wound healing noted in aging. We, therefore, compared the responses of dermal fibroblasts from young and elderly individuals (26, 29, 65, 89, 90, and 92 years of age) to transforming growth factor‐β1 (TGF‐β1) with respect to: (1) the synthesis of type I collagen and SPARC (two extracellular matrix proteins that are highly expressed by dermal fibroblasts during the remodeling phase of wound repair) and (2) the contraction of collagen gels, an in vitro assay of wound contraction. With the exception of one young donor, all cultures exposed for 44 hours to 10 ng/ml TGF‐β1 exhibited a 1.6‐ to 5.5‐fold increase in the levels of secreted type 1 collagen and SPARC, relative to untreated cultures, and exhibited a 2.0‐ to 6.2‐fold increase in the amounts of the corresponding mRNAs. Moreover, the dose‐response to TGF‐β1 (0.1–10 ng/ml), as determined by synthesis of type I collagen and SPARC mRNA, was as vigorous in cells from aged donors as in cells from a young donor. In assays of collagen gel contraction, fibroblasts from all donors were stimulated to a similar degree by 10 ng/ml TGF‐β1. In conclusion, cells from both young and aged donors exhibited similar biosynthetic and contractile properties with exposure to TGF‐β1. It therefore appears that the impaired wound healing noted in the aged does not result from a failure of their dermal fibroblasts to respond to this cytokine. © 1994 Wiley‐Liss, Inc.

[1]  M. Reed,et al.  Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[2]  T. McCaffrey,et al.  Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. , 1993, Molecular biology of the cell.

[3]  E. Sage,et al.  Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts , 1993, Journal of cellular physiology.

[4]  K. Takeda,et al.  Similar, but not identical, modulation of expression of extracellular matrix components during in vitro and in vivo aging of human skin fibroblasts , 1992, Journal of cellular physiology.

[5]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges. , 1992 .

[6]  E. Ruoslahti,et al.  Transforming growth factor-beta in disease: the dark side of tissue repair. , 1992, The Journal of clinical investigation.

[7]  G F Pierce,et al.  Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. , 1992, The American journal of pathology.

[8]  S. Weinstein,et al.  Age‐related changes in hyaluronan, proteoglycan, collagen, and osteonectin synthesis by human bone cells , 1992, Journal of cellular physiology.

[9]  E. Sage,et al.  Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells. , 1992, Experimental cell research.

[10]  R. Ross,et al.  The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Foreman,et al.  Control of scarring in adult wounds by neutralising antibody to transforming growth factor β , 1992, The Lancet.

[12]  P. Bornstein,et al.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. , 1991, The Journal of biological chemistry.

[13]  A. Lambowitz,et al.  Diverse gene sequences are overexpressed in werner syndrome fibroblasts undergoing premature replicative senescence , 1991, Molecular and cellular biology.

[14]  P. Hanawalt,et al.  Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing , 1991, Journal of cellular physiology.

[15]  M. Iruela-Arispe,et al.  Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  J. Davidson,et al.  Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. , 1991, The Journal of investigative dermatology.

[17]  R. McAnulty,et al.  Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. , 1991, The Biochemical journal.

[18]  Thomas A. Mustoe, MD, FACS,et al.  Quantitative analysis of inflammatory cell influx, procollagen type I synthesis, and collagen cross-linking in incisional wounds: influence of PDGF-BB and TGF-beta 1 therapy. , 1991, The Journal of laboratory and clinical medicine.

[19]  E. Sage,et al.  The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Wrana,et al.  Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. , 1991, European journal of biochemistry.

[21]  E. Vuorio,et al.  Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea. , 1991, The Journal of rheumatology.

[22]  M. Iruela-Arispe,et al.  Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[23]  J. Termine Cellular activity, matrix proteins, and aging bone , 1990, Experimental Gerontology.

[24]  M. Martin,et al.  Fibronectin and collagen gene expression during in vitro ageing of pig skin fibroblasts. , 1990, Experimental cell research.

[25]  Harold L. Moses,et al.  TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights , 1990, Cell.

[26]  P. Canney,et al.  Transforming growth factor beta: a promotor of late connective tissue injury following radiotherapy? , 1990, The British journal of radiology.

[27]  J. R. Smith,et al.  Replicative senescence of human skin fibroblasts correlates with a loss of regulation and overexpression of collagenase activity. , 1989, Experimental cell research.

[28]  E. A. Everitt,et al.  SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix , 1989, The Journal of cell biology.

[29]  H. Sage,et al.  The calcium-binding protein SPARC is secreted by Leydig and Sertoli cells of the adult mouse testis. , 1989, Biology of reproduction.

[30]  M. Iruela-Arispe,et al.  Distribution of the calcium-binding protein SPARC in tissues of embryonic and adult mice. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  Thomas A. Mustoe, MD, FACS,et al.  Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Funk,et al.  SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation. , 1989, Journal of molecular and cellular cardiology.

[33]  L Orci,et al.  Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Bornstein,et al.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  V. Duance,et al.  Type I and III collagen content and fibre distribution in normal human skin during ageing , 1987, The British journal of dermatology.

[36]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[37]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[38]  H. Moses,et al.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. , 1987, The Journal of clinical investigation.

[39]  B. Hogan,et al.  Evidence from molecular cloning that SPARC, a major product of mouse embryo parietal endoderm, is related to an endothelial cell ‘culture shock’ glycoprotein of Mr 43,000. , 1986, The EMBO journal.

[40]  B. Gilchrest,et al.  Growth factor responsiveness declines during adulthood for human skin-derived cells , 1986, Mechanisms of Ageing and Development.

[41]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[43]  T. Ide,et al.  Loss of responsiveness in senescent human TIG-1 cells to the DNA synthesis-inducing effect of various growth factors , 1984, Mechanisms of Ageing and Development.

[44]  B. Gilchrest,et al.  Growth factor responsiveness of cultured human fibroblasts declines with age. , 1983, Journal of gerontology.

[45]  J. Myers,et al.  Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. , 1982, Nucleic acids research.

[46]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[47]  C. Harley,et al.  Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulinlike activity. , 1981, The Journal of clinical investigation.

[48]  S. Shuster,et al.  The influence of age and sex on skin thickness, skin collagen and density , 1975, The British journal of dermatology.

[49]  V. J. Selmanowitz,et al.  SECTION OF BIOLOGICAL AND MEDICAL SCIENCES: LEVELS OF BIOLOGICAL FUNCTIONS WITH AGING* , 1969 .

[50]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[51]  H. Goldberg,et al.  Immunohistochemical localization of SPARC (osteonectin) and denatured collagen and their relationship to remodelling in rat dental tissues. , 1990, Archives of oral biology.

[52]  V. Cristofalo,et al.  Progressive loss of the proliferative response of senescing WI-38 cells to platelet-derived growth factor, epidermal growth factor, insulin, transferrin, and dexamethasone. , 1984, Journal of gerontology.

[53]  E. Schneider,et al.  Skin fibroblast cultures derived from members of the Baltimore longitudinal study: a new resource for studies of cellular aging. , 1981, Cytogenetics and cell genetics.

[54]  J. Uitto,et al.  Protocollagen proline hydroxylase activity in the skin of normal human subjects and of patients with scleroderma. , 1969, Scandinavian journal of clinical and laboratory investigation.